Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1167

1.

Is Ki67 prognostic for aggressive prostate cancer? A multicenter real-world study.

Fantony JJ, Howard LE, Csizmadi I, Armstrong AJ, Lark AL, Galet C, Aronson WJ, Freedland SJ.

Biomark Med. 2018 Jun 15. doi: 10.2217/bmm-2017-0322. [Epub ahead of print]

PMID:
29902938
2.

Building a Citizen Pscientist: Advancing Patient-Centered Psoriasis Research by Empowering Patients as Contributors and Analysts.

Sanchez IM, Shankle L, Wan MT, Afifi L, Wu JJ, Doris F, Bridges A, Boas M, Lafoy B, Truman S, Orbai AM, Takeshita J, Gelfand JM, Armstrong AW, Siegel MP, Liao W.

Dermatol Ther (Heidelb). 2018 Jun 6. doi: 10.1007/s13555-018-0242-5. [Epub ahead of print]

PMID:
29876724
3.

Identifying a Core Domain Set to Assess Psoriasis in Clinical Trials.

Callis Duffin K, Merola JF, Christensen R, Latella J, Garg A, Gottlieb AB, Armstrong AW.

JAMA Dermatol. 2018 Jun 6. doi: 10.1001/jamadermatol.2018.1165. [Epub ahead of print]

PMID:
29874367
4.

Can RECIST response predict success in phase 3 trials in men with metastatic castration-resistant prostate cancer?

Brown LC, Sonpavde G, Armstrong AJ.

Prostate Cancer Prostatic Dis. 2018 Jun 1. doi: 10.1038/s41391-018-0049-6. [Epub ahead of print]

PMID:
29858595
5.

Proceedings of the 2017 GRAPPA Collaborative Research Network Meeting.

Jadon DR, Chandran V, Stober C, Ogdie A, Armstrong AW, Callis Duffin K, Gladman DD, Helliwell PS, O'Sullivan D, de Wit M, FitzGerald O, Ritchlin CT.

J Rheumatol Suppl. 2018 Jun;94:54-61. doi: 10.3899/jrheum.180141.

PMID:
29858357
6.

Report of the Skin Research Working Groups from the GRAPPA 2017 Annual Meeting.

Gottlieb AB, Coates LC, van Mens LJJ, Armstrong AW, Merola JF.

J Rheumatol Suppl. 2018 Jun;94:40-43. doi: 10.3899/jrheum.180137.

PMID:
29858353
7.

Automated telephone follow-up for smoking cessation in smokers with coronary heart disease: a randomized controlled trial.

Reid RD, Aitken DA, Mullen KA, McDonnell L, Armstrong A, Leblanc AG, Slovinec-D'Angelo M, Pipe AL.

Nicotine Tob Res. 2018 May 25. doi: 10.1093/ntr/nty108. [Epub ahead of print]

PMID:
29800420
8.

Phase 3 Assessment of the Automated Bone Scan Index as a Prognostic Imaging Biomarker of Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial.

Armstrong AJ, Anand A, Edenbrandt L, Bondesson E, Bjartell A, Widmark A, Sternberg CN, Pili R, Tuvesson H, Nordle Ö, Carducci MA, Morris MJ.

JAMA Oncol. 2018 May 17. doi: 10.1001/jamaoncol.2018.1093. [Epub ahead of print]

PMID:
29799999
9.

Effect of 2 Psoriasis Treatments on Vascular Inflammation and Novel Inflammatory Cardiovascular Biomarkers: A Randomized Placebo-Controlled Trial.

Mehta NN, Shin DB, Joshi AA, Dey AK, Armstrong AW, Duffin KC, Fuxench ZC, Harrington CL, Hubbard RA, Kalb RE, Menter A, Rader DJ, Reilly MP, Simpson EL, Takeshita J, Torigian DA, Werner TJ, Troxel AB, Tyring SK, Vanderbeek SB, Van Voorhees AS, Playford MP, Ahlman MA, Alavi A, Gelfand JM.

Circ Cardiovasc Imaging. 2018 Jun;11(6):e007394. doi: 10.1161/CIRCIMAGING.117.007394.

PMID:
29776990
10.

The developmental transcriptomes of two sea biscuit species with differing larval types.

Armstrong AF, Grosberg RK.

BMC Genomics. 2018 May 18;19(1):368. doi: 10.1186/s12864-018-4768-9.

11.

Comparison of mental health outcomes among adults with psoriasis on biologic versus oral therapies: a population-based study.

Salame N, Ehsani-Chimeh N, Armstrong AW.

J Dermatolog Treat. 2018 May 29:1-6. doi: 10.1080/09546634.2018.1476654. [Epub ahead of print]

PMID:
29757044
12.

In vitro cytocompatibility evaluation of poly(octamethylene citrate) monomers toward their use in orthopedic regenerative engineering.

Ma C, Gerhard E, Lin Q, Xia S, Armstrong AD, Yang J.

Bioact Mater. 2018 Feb 3;3(1):19-27. doi: 10.1016/j.bioactmat.2018.01.002. eCollection 2018 Mar.

13.

Precarious preferences wipe out a butterfly population.

Armstrong A.

Nature. 2018 May;557(7704):171. doi: 10.1038/d41586-018-05068-2. No abstract available.

PMID:
29743699
14.

Phase II study of single-agent cabozantinib in patients with recurrent clear cell ovarian, primary peritoneal or fallopian tube cancer (NRG-GY001).

Konstantinopoulos PA, Brady WE, Farley J, Armstrong A, Uyar DS, Gershenson DM.

Gynecol Oncol. 2018 May 5. pii: S0090-8258(18)30850-3. doi: 10.1016/j.ygyno.2018.04.572. [Epub ahead of print]

PMID:
29739622
15.

Conformational Plasticity of the Immunoglobulin Fc Domain in Solution.

Remesh SG, Armstrong AA, Mahan AD, Luo J, Hammel M.

Structure. 2018 Apr 18. pii: S0969-2126(18)30121-7. doi: 10.1016/j.str.2018.03.017. [Epub ahead of print]

16.

Patient Perceptions of Clear/Almost Clear Skin in Moderate-to-Severe Plaque Psoriasis: Results of the Clear About Psoriasis Worldwide Survey.

Armstrong A, Jarvis S, Boehncke WH, Rajagopalan M, Fernández-Peñas P, Romiti R, Bewley A, Vaid B, Huneault L, Fox T, Sodha M, Warren RB.

J Eur Acad Dermatol Venereol. 2018 May 6. doi: 10.1111/jdv.15065. [Epub ahead of print]

PMID:
29730888
17.

A Multicenter Program to Implement the Canadian C-Spine Rule by Emergency Department Triage Nurses.

Stiell IG, Clement CM, Lowe M, Sheehan C, Miller J, Armstrong S, Bailey B, Posselwhite K, Langlais J, Ruddy K, Thorne S, Armstrong A, Dain C, Perry JJ, Vaillancourt C.

Ann Emerg Med. 2018 May 2. pii: S0196-0644(18)30300-7. doi: 10.1016/j.annemergmed.2018.03.033. [Epub ahead of print]

PMID:
29729811
18.

Insulin signaling acts in adult adipocytes via GSK-3β and independently of FOXO to control Drosophila female germline stem cell numbers.

Armstrong AR, Drummond-Barbosa D.

Dev Biol. 2018 Aug 1;440(1):31-39. doi: 10.1016/j.ydbio.2018.04.028. Epub 2018 May 2.

PMID:
29729259
19.

Anxiety and depression in patients with moderate-to-severe psoriasis and comparison of change from baseline after treatment with guselkumab versus adalimumab: Results from the Phase 3 VOYAGE 2 study.

Gordon KB, Armstrong AW, Han C, Foley P, Song M, Wasfi Y, You Y, Shen YK, Reich K.

J Eur Acad Dermatol Venereol. 2018 Apr 28. doi: 10.1111/jdv.15012. [Epub ahead of print]

PMID:
29706008
20.

Fecal Microbiota Composition Drives Immune Activation in HIV-infected Individuals.

Neff CP, Krueger O, Xiong K, Arif S, Nusbacher N, Schneider JM, Cunningham AW, Armstrong A, Li S, McCarter MD, Campbell TB, Lozupone CA, Palmer BE.

EBioMedicine. 2018 Apr;30:192-202. doi: 10.1016/j.ebiom.2018.03.024. Epub 2018 Mar 26.

Supplemental Content

Loading ...
Support Center